| 产品名称 | ReVacc Scientific T53L53 | VSV-Pseudovirus_MERS-CoV Spike with luciferase reporter |
|---|---|
| 目录号 | T53L53 |
| 别名 | VSV-Pseudovirus_MERS-CoV Spike with luciferase reporter |
| 外观 | 见COA |
| 分子量 | N/A |
| CAS | N/A |
| 溶解度 | |
| 存储条件 | 见COA |
| 保存时间 | 见COA |
| 备注1 | |
| 备注2 |
| 目录号 | 规格 | 价格 | 库存状态 | |
| T53L53 | 200 μl; 1000 μl | 咨询 | 咨询 |
ReVacc Scientific T53L53 | VSV-Pseudovirus_MERS-CoV Spike with luciferase reporter
品名:VSV-Pseudovirus_MERS-CoV Spike with luciferase reporter
货号:T53L53
品牌:ReVacc Scientific
规格:200 μl; 1000 μl
产品描述
Organism:Middle East respiratory syndrome coronavirus (MERS-CoV), the virus caused 2015 outbreak in Republic of Korea.
This pseudotyped virus uses recombinant vesicular stomatitis virus (rVSV) to carry S protein of Middle East respiratory syndrome coronavirus (MERS-CoV, GenBank No. JX869059.2), which was designed by codon optimizing the S sequence for mammalian expression, and had 16-aa cytoplasmic tail truncation for optimal infection. As pseudovirus infectivity of rVSV without its original G is restricted to a single round of replication, the pseudotypes can be handled using BSL-2 containment practices. Infection of cells with this pseudotyped virus carrying luciferase reporter results in high level luciferase activity. See our titration result showing the undiluted pseudovirus (green) generates signal 100,000-fold higher than uninfected control (cell alone as background in blue). We also evaluated the neutralizing activity of our MERS Positive control mAb and one published mAb called MERS27 by using this pseudotyped virus, see results.